ArticleAnnals of epidemiology2025
Cardiovascular disease mortality trends in young adults aged 18-34 years, United States, 2000-2023.
Article in Annals of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Temporal and Regional Trends in Cardiovascular Mortality Associated With Diabetes Mellitus: A Nationwide Analysis From 1999 to 2020 in the United States.Health science reports · 2026Article
- Trends in cardiovascular health based on Life's Essential 8 among Korean adults, 2007-2023.American journal of preventive cardiology · 2026Article
- Computed Tomography in the Evaluation and Identification of Features of Coronary Atherosclerosis Between European and Asian Populations in Kazakhstan.Medicina (Kaunas, Lithuania) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study examines national trends in mortality from cardiovascular disease (CVD) and select subtypes among U.S. young adults aged 18-34 years from 2000 to 2023.
methodsNational mortality data from the National Vital Statistics System were used to identify CVD, heart disease, stroke, and hypertension-related CVD deaths among U.S. residents aged 18-34 from 2000 to 2023. Crude and age-standardized death rates were calculated overall and by age group, sex, and race and ethnicity. Temporal trends were calculated as percent change using a log-linear model.
resultsFrom 2000-2023, age-standardized CVD and heart disease death rates among young adults did not statistically change (percent change: -2.2 % [95 % CI: -7.8, 3.7] and -2.4 % [95 % CI: -8.3 %, 3.8 %], respectively). Stroke death rates decreased (percent change: -15.7 % [-21.0 %, -10.0 %])). However, hypertension-related CVD death rates increased by 78.5 % [95 % CI: 63.6 %, 94.7 %]). Patterns across demographic groups were broadly similar.
conclusionDespite stability or modest declines in CVD death rates among young adults, hypertension-related CVD death rates increased sharply during 2000-2023. These findings merit public health action and underscore the need for better identification and management of hypertension and other CVD risk factors among young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.